Invus Advisors, L.L.C., 10% Owner at LEXICON PHARMACEUTICALS, INC./DE (LXRX), bought 669,052 shares at $2.00 ($1.3M) on 2008-04-30, disclosed to the SEC on 2008-05-02.
Open-market purchase of $1.3M LXRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| BUFF | SELL | 2015-07-27 | $569.3M | — | Filing → |
| LXRX | BUY | 2009-10-15 | $23.2M | — | Filing → |
| LXRX | BUY | 2007-08-24 | — | — | Filing → |